James Michael Hillis, D.Phil., M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurology | 3 | 2022 | 764 | 1.190 |
Why?
|
| Education, Medical | 4 | 2018 | 1722 | 0.890 |
Why?
|
| Pneumothorax | 1 | 2022 | 378 | 0.670 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2018 | 16 | 0.650 |
Why?
|
| Splenectomy | 1 | 2019 | 394 | 0.600 |
Why?
|
| Cuprizone | 1 | 2016 | 9 | 0.580 |
Why?
|
| Lateral Ventricles | 2 | 2021 | 146 | 0.570 |
Why?
|
| Students, Medical | 4 | 2012 | 1862 | 0.560 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2016 | 157 | 0.550 |
Why?
|
| Confusion | 1 | 2018 | 275 | 0.550 |
Why?
|
| Neuromyelitis Optica | 1 | 2019 | 252 | 0.510 |
Why?
|
| Neurologic Examination | 1 | 2018 | 929 | 0.510 |
Why?
|
| Artificial Intelligence | 3 | 2023 | 2210 | 0.500 |
Why?
|
| Demyelinating Diseases | 1 | 2016 | 354 | 0.470 |
Why?
|
| Personality Disorders | 1 | 2018 | 713 | 0.460 |
Why?
|
| Curriculum | 2 | 2018 | 3603 | 0.420 |
Why?
|
| Galectin 3 | 3 | 2021 | 228 | 0.420 |
Why?
|
| Autoimmunity | 1 | 2019 | 1349 | 0.380 |
Why?
|
| Australia | 5 | 2012 | 1167 | 0.360 |
Why?
|
| Training Support | 1 | 2010 | 113 | 0.350 |
Why?
|
| Health Education | 1 | 2012 | 1056 | 0.260 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1403 | 0.240 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 1007 | 0.220 |
Why?
|
| Neurogenesis | 2 | 2021 | 838 | 0.210 |
Why?
|
| Teaching | 1 | 2010 | 1173 | 0.210 |
Why?
|
| Career Choice | 1 | 2008 | 743 | 0.200 |
Why?
|
| Schools, Medical | 1 | 2008 | 879 | 0.200 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1619 | 0.190 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2021 | 42 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 2291 | 0.180 |
Why?
|
| Information Dissemination | 1 | 2008 | 1099 | 0.170 |
Why?
|
| Cerebrum | 1 | 2021 | 137 | 0.170 |
Why?
|
| New Zealand | 2 | 2010 | 355 | 0.160 |
Why?
|
| Inflammation | 2 | 2021 | 10629 | 0.150 |
Why?
|
| General Surgery | 1 | 2008 | 1636 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2008 | 3740 | 0.140 |
Why?
|
| Nervous System Autoimmune Disease, Experimental | 1 | 2015 | 2 | 0.140 |
Why?
|
| Radiography, Thoracic | 1 | 2022 | 1265 | 0.140 |
Why?
|
| Internet | 1 | 2008 | 3058 | 0.130 |
Why?
|
| Olfactory Bulb | 1 | 2016 | 200 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 528 | 0.130 |
Why?
|
| Brain | 3 | 2021 | 26345 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2010 | 4245 | 0.120 |
Why?
|
| Immunity | 1 | 2021 | 1013 | 0.120 |
Why?
|
| Oligodendroglia | 1 | 2016 | 517 | 0.110 |
Why?
|
| Quality of Life | 2 | 2012 | 12788 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2012 | 5787 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2015 | 346 | 0.100 |
Why?
|
| Corpus Callosum | 1 | 2016 | 736 | 0.100 |
Why?
|
| International Cooperation | 1 | 2018 | 1419 | 0.100 |
Why?
|
| Radiography | 1 | 2022 | 7010 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 1081 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 1152 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2016 | 2725 | 0.090 |
Why?
|
| Radiology | 1 | 2023 | 2099 | 0.080 |
Why?
|
| Humans | 14 | 2023 | 743811 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4437 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7270 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9731 | 0.060 |
Why?
|
| Middle Aged | 5 | 2022 | 213241 | 0.060 |
Why?
|
| Female | 7 | 2022 | 380020 | 0.060 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 851 | 0.050 |
Why?
|
| Prognosis | 1 | 2022 | 29052 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3079 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10477 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9975 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2023 | 476 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 20121 | 0.040 |
Why?
|
| Workflow | 1 | 2023 | 847 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 12066 | 0.040 |
Why?
|
| Male | 5 | 2022 | 349776 | 0.040 |
Why?
|
| Commerce | 1 | 2023 | 592 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18027 | 0.040 |
Why?
|
| Cell Movement | 2 | 2021 | 5216 | 0.040 |
Why?
|
| Adolescent | 2 | 2022 | 85729 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2012 | 4687 | 0.030 |
Why?
|
| Theilovirus | 1 | 2015 | 11 | 0.030 |
Why?
|
| Poliomyelitis | 1 | 2015 | 103 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77410 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 213889 | 0.030 |
Why?
|
| Consensus | 1 | 2021 | 2954 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 168660 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2021 | 2528 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 81154 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8337 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 3503 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 56392 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14563 | 0.010 |
Why?
|
| Child | 2 | 2021 | 77637 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39001 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23398 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 21824 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 35409 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 163178 | 0.000 |
Why?
|